Previous studies report that selected topical isoflavonoids are immunoprotective in both mice and humans, when applied following UV irradiation. Isoflavonoids have documented antioxidant activity, but their mechanism of immunomodulation remains unclear. This study examines whether photoimmunoprotection by the isoflavonoids might result from their interaction with one cutaneous antioxidant known to modulate UV photodamage, metallothionein (MT). In mice bearing a null mutation for MT-I and -II, we found that immunoprotection by the isoflavonoid 4 0 ,7-dihydroxyisoflavane (equol) against solar-simulated UV radiation (SSUV) or exogenous cis-urocanic acid was abrogated. Topical equol did not activate MT expression in normal mouse skin, but markedly enhanced the increase in MT expression in murine epidermis following SSUV irradiation. Normal human skin, unlike murine, expressed MT in the basal epidermis. Following SSUV irradiation, topical application of the related synthetic isoflavonoid NV-07a to human skin also markedly enhanced epidermal MT expression. The NV-07a has been reported previously to protect humans against the UV suppression of Mantoux reactions. Thus, epidermal MT expression appears to protect against photoimmunosuppression in both human and mouse skin. We speculate that equol and its related derivative NV-07a may activate the MT gene synergistically with SSUV, to produce the enhanced immunoprotective effect.
INTRODUCTION
The flavonoids comprise a group of phytochemicals that have useful biological activities including anti-cancer and antiinflammatory effects (Middleton and Kandaswami, 1992; Adlercreutz, 1995) , generally agreed to result from their potential as antioxidants. One such isoflavone, 4 0 ,7-dihydroxyisoflavane (equol), which is a natural metabolite of the primary isoflavone daidzein, has been found to have strong protective effects against UV irradiation of mouse skin. In the hairless mouse irradiated acutely with solar-simulated UV radiation (SSUV), topically applied equol reduced both the resultant cutaneous inflammation and the suppression of the contact hypersensitivity (CHS) reaction (Widyarini et al., 2001) . The immunoprotection appeared to result from equol inhibiting the downstream actions of the immunosuppressive UV photoproduct in the skin, cis-urocanic acid. Topical equol has also been found to reduce the severity of mouse skin carcinogenesis induced by chronic exposure to SSUV (Widyarini et al., 2005) , which is consistent with its photoimmunoprotective activity (Reeve and Ley, 2004) . Additionally, a synthetic derivative of equol, the isoflavonoid NV-07a, has recently been reported to reduce the SSUVinduced suppression of the Mantoux reaction in a cohort of humans. The report provides the first indication that this isoflavonoid applied topically may have useful photoimmunoprotective properties in humans (Friedmann et al., 2004) . Although isoflavonoids including equol have been demonstrated to have significant antioxidant activity (Mitchell et al., 1998) , the mechanisms by which they mediate these UVprotective effects have remained unclear.
In this study, we examine the possibility that isoflavonoid photoprotection might result from an interaction with endogenous cutaneous antioxidants that have been established as playing a role in protection against UV radiation effects. The metallothioneins (MTs) comprise one class of candidate molecule. These small highly conserved sulfydrylrich proteins are best recognized for their function in maintaining zinc homeostasis, and in chelating and detoxifying environmental heavy metal pollutants. Four isoform families of MTs have been described, but most is known about the co-ordinately expressed MT-I and -II. They have regulating effects on cell proliferation, apoptosis, and the cellular redox balance due to their antioxidant properties (Miles et al., 2000) . The MTs are readily inducible, typically by heavy metals and by various oxidative stressors including UV radiation. Evidence has been accumulating for a photoprotective function of induced MT in both cultured cells and in the skin (Hanada et al., 1991; Hanada et al., 1993) . In mice with a targeted mutation of the MT-I and -II genes, UVB irradiation resulted in a reduction in apoptotic sunburn cells (Hanada et al., 1998) , an increased susceptibility to the suppression of CHS, and an exacerbated inflammatory sunburn reaction . The photoprotective mechanism of MT appears to be associated with its ability to reduce oxidative radicals in the skin, and a role for cutaneous MT as an important endogenous antioxidant is therefore indicated (Hanada et al., 1993) .
Here, we report experiments in mice and humans in which an MT involvement in the photoimmunoprotective effects of topically applied isoflavonoid lotions was sought. Immune status was measured in the mice by the CHS reaction, and immunohistochemical evidence for cutaneous MT expression was sought in both murine and human skin.
RESULTS

Effect of topical equol on SSUV-and cis-urocanic acid-induced suppression of CHS in mice
Irradiation on 3 consecutive days with SSUV suppressed the CHS reaction to oxazolone in both wild-type and MTÀ/À mice; however, the MTÀ/À mice were significantly more sensitive, as has been reported previously , developing a greater degree of immunosuppression (62% suppression) than the MT þ / þ mice (42% suppression) ( Figure 1 ; Po0.001). Topical application alone of equol lotions containing between 2.5 and 10 mM equol did not significantly affect the CHS reaction, but produced an equol concentration-dependent reduction in the severity of the immunosuppression in the SSUV-irradiated MT þ / þ mice ( Figure 1 ). Thus, treatment post-irradiation with the highest test concentration, 10 mM equol, resulted in only 14% suppression of CHS. This protective effect was absent in MTÀ/À mice and these remained severely immunosuppressed by the SSUV (62-74% suppression of CHS).
When the mice were treated topically with exogenous cisurocanic acid, the immunosuppression-mediating cutaneous photoproduct, there was again significantly (Po0.001) greater suppression of CHS in MTÀ/À mice (69% suppression) than in MT þ / þ mice (58% suppression), as reported previously  Figure 2 ). Consistent with the effect in SSUV-immunosuppressed mice, topical 10 mM equol lotion was strongly protective against cis-urocanic acid in MT þ / þ mice and reduced the degree of suppression to 29%. In contrast, MTÀ/À mice treated with cis-urocanic acid and equol remained 72% immunosuppressed.
Effect of topical 10 mM equol and SSUV on MT expression in mouse skin
Reverse transcriptase-polymerase chain reaction detection of MT-I mRNA was compared with the housekeeping gene heme oxygenase-2, the bands were analyzed semi-quantitatively in duplicate, and the average ratios of MT-I/heme oxygenase-2 were calculated for three mice and are shown in Figure 3 . MT-I gene expression was detectable in normal mouse skin, and was increased modestly but significantly (Po0.05) by 6% at 3 hours post-SSUV. Equol lotion application alone in the absence of SSUV did not alter MT-I mRNA level, but when SSUV irradiation was followed by equol lotion application, MT-I mRNA expression was increased by 11% (Po0.05). This mRNA induction appeared to be greater than the induction in response to SSUV alone; however, the enhancement did not attain statistical significance (paired t-test).
Immunopositive MT protein was very weakly evident in the normal mouse epidermis ( Figure 4 ). However, at 72 hours -post-SSUV, when the epidermal hyperplasia is well developed and MT expression has been reported to be maximal -there was significant but discontinuous expression of MT in the epidermal basal layer cells. Mouse skin treated only with equol lotion was not different at 72 hours from untreated normal skin, but when equol lotion was applied following SSUV irradiation, there was strong enhancement of the MT expression in the epidermal basal cells compared with the response to SSUV alone. This treatment also protected against the development of the epidermal hyperplasia seen following SSUV alone. Occasional immunopositive dendritic cells were found in the dermis following SSUV exposure, but were much less evident in the dermis of SSUV þ equol-treated skin.
Effect of topical 200 mM NV-07a and SSUV on MT expression in human skin
Human skin was found to express MT constitutively in approximately 50% of epidermal basal cells, but not in the suprabasal layers ( Figure 5 ). At 24 hours post-SSUV, a time point when UV-induced epidermal MT has been reported to have reached a plateau in human skin (Anstey et al., 1996; Ablett et al., 2003) , there was apparent enhancement of MT expression and an increase in the percentage of positivestaining epidermal cells in two of five subjects. SSUV exposure also induced a number of immunopositive cells with dendritic appearance in the dermis of all the subjects. However, in all five subjects, treatment with NV-07a lotion application following SSUV exposure resulted in a marked increase in epidermal MT expression, both in intensity and in immunopositive cell number, with the MT staining extending from the basal layer into the suprabasal epidermal strata. On the other hand, the SSUV-elevated percentage of MTexpressing dermal dendritic cells, illustrated at a higher magnification in Figure 5 , was not further enhanced by topical NV-07a lotion. Counting of immunopositive epidermal cells revealed an increase of between 0 and 11% in response to SSUV at 24 hours, not statistically significant (paired t-test), but a marked and statistically significant increase of between 7 and 26%, averaging 16% increase (P ¼ 0.007) when SSUV was followed by NV-07a lotion application (Table 1) . 
Base lotion SSUV+Base lotion
Equol lotion SSUV+equol lotion 
DISCUSSION
This study has shown that in normal (MT þ / þ ) haired mice, moderately inflammatory SSUV exposure that caused significant suppression of the CHS reaction induced MT-positive dendritic cells in the dermis at 72 hours, and an increase in MT expression in the basal epidermis. The topical application of equol lotions following SSUV exposure had several effects: equol attenuated the SSUV-induced hyperplasia of the epidermal layer, attenuated the suppression of CHS, and significantly increased the presence of epidermal MT, but inhibited the expression of MT in dermal dendritic cells. Furthermore, the capacity of topical equol lotions to attenuate the suppression of CHS by SSUV was abrogated in the absence of MT-I and -II (MTÀ/À mice). In untreated mouse skin, MT was only very weakly expressed, and equol lotion application alone did not appear to upregulate MT expression. In humans, in agreement with the observations in mice, SSUV exposure at a similarly moderately erythemogenic dose that had previously been shown to suppress the Mantoux reaction (Friedmann et al., 2004) induced MT-positive dendritic cells in the dermis at 24 hours. Post-SSUV topical application of NV-07a lotion dramatically increased the presence of epidermal MT. In contrast to the mouse skin, MT was consistently expressed in the basal epidermal cells of untreated human skin from non-sun-exposed areas. It was not clear that epidermal thickness was altered by SSUV or NV-07a. Although two of five subjects did show an increase, SSUV itself did not cause a statistically significant increase in the level of epidermal MT expression. Additionally, NV-07a lotion post-SSUV did not appear to reduce the number of MTpositive dermal dendritic cells. The continuing presence of MT-positive dermal cells in human skin treated with SSUV þ NV-07a, but apparent absence in the mouse dermis, may be related to the failure to observe a reduction in the human inflammatory erythema reaction by the treatment at this study time point and in a previous study (Friedmann et al., 2004) . On the other hand, topical equol lotions have been demonstrated to reduce the inflammatory reaction in mice (Widyarini et al., 2001) , suggesting that it is epidermal MT expression that is associated with immunoprotection from SSUV, consistent with this localization of the important photoreceptor for immunosuppression, trans-urocanic acid.
In this study, the very weak MT expression in the normal mouse skin was in agreement with previous observations in normal-haired mice , but differed from the universal expression of MT, predominantly in basal keratinocytes in untreated human skin, which was in agreement with other reports (Van den Oord and De Ley, 1994; Anstey et al., 1996; Santucci et al., 2000) . We found MT expression in approximately 50% of the epidermal cells of untreated human skin in non-sun-exposed sites, which may indicate a constitutive response to environmental factors from which laboratory mice are protected. The expression of MT at distant non-exposed sites in sun-irradiated humans has been reported recently (Ablett et al., 2003) .
Following a single exposure of UVB radiation from a fluorescent tube source, normal-haired mice have been reported to continue to respond with increasing cutaneous MT expression until 72 hours . Therefore, this time point was selected to examine irradiated MT þ / þ mice. In that study, unfiltered UVB radiation had induced MT initially in the dermal fibroblasts of the mouse, with increasing expression developing in dermal inflammatory cells and then in the epidermal basal layer. In human skin, narrow band UVB radiation at 300 nm was also reported to induce MT expression initially in the superficial dermis from 2 hours post-irradiation, with increased expression encompassing the basal epidermal keratinocytes that fluctuated between 8 and 48 hours (Anstey et al., 1996) . Therefore, the earlier time point of 24 hours was selected to examine MT expression in humans. It is notable that at these test time points, using SSUV exposure rather than the UVB of the earlier studies, we did not observe a predominance of MT expression in dermal fibroblasts. The basal epidermal cells appeared to be the major responders in both mice and humans. Thus, there may be important spectral determinants for the target cell populations. The predominantly epidermal expression of SSUV-induced MT is consistent with previous observations in sunlight-exposed human skin (Ablett et al., 2003) .
In mice, this study has demonstrated the dependence of the photoimmunoprotection by equol on the induction of MT. The immunohistochemical evidence for marked upregulation of MT expression in the murine and human epidermis following SSUV þ equol and NV-07a, respectively, supports such a role. When the previously established protective effect of topical NV-07a against the SSUV suppression of the Mantoux reaction in humans is considered (Friedmann et al., 2004) , it seems very likely that MT expression in the skin provides an important protective mechanism against photoimmunosuppression in both mouse and human. This pathway appears to be significantly enhanced following equol or NV-07a administration.
Interestingly, equol lotion alone did not affect MT expression, at least in the mouse, nor did it have an immunomodulating effect. Therefore, it is unclear how these isoflavonoids might stimulate MT inducibility by SSUV. Regulation of the MT genes has been reported to involve metals, steroid hormones, redox-active molecules, and various cytokines (Sciavolino and Vilcek, 1995; Nishimura et al., 2000; Ablett et al., 2003) , some recognized also as UVreleased mediators on the skin. A small number of reports have linked other isoflavones with both direct and indirect metal-mediated MT induction in cultured cell systems (Kameoka et al., 1999; Kuo and Leavitt, 1999; Kuo et al., 2001) , implying possible synergism with secondary response elements (Hua et al., 2003) . Future studies may define these mechanisms better.
In conclusion, our results are consistent with the hypothesis that the photoprotection afforded by topical equol and NV-07a is dependent on the level of cutaneous MT expression, in both mouse and human skin. This implicates these isoflavonoids as exogenous antioxidants, in a role interacting with the endogenous cellular antioxidant activity of the skin for a protective outcome. Whether the induction of cutaneous MT persists in chronically UV-irradiated skin, and www.jidonline.org 201 S Widyarini et al.
whether this MT might attenuate photoaging and/or photocarcinogenesis, will be the subject of further studies.
MATERIALS AND METHODS
Mice
The MT-I and -II null mouse (Michalska and Khoo, 1993 ), which appears phenotypically normal, and its matched wild-type MT þ / þ , derived from a C57Bl/6-Ola129 cross, were obtained from the Veterinary Science breeding colony. They were maintained in conventional wire-topped plastic caging on compressed paper bedding, at 251C, and were fed normal laboratory rodent stockfeed (Gordons Specialty Stockfeeds, Yanderra, Australia) and tap water ad lib. The studies were conducted according to the NSW Animal Welfare Act, with approval from the University of Sydney Animal Ethics Committee. Female mice aged 8-10 weeks were clipped free of dorsal fur (Oster clippers, Oster Manufacturing, Milwaukee, WI) 24 hours before beginning topical treatment. Mice were selected for inclusion in experiments when in the resting phase (pink skin) of the hair growth cycle.
Human volunteers
Five volunteers (age range 30-59 years, one woman) were recruited. Participants were healthy volunteers with skin type I or II (ie fair skin, which tans poorly and burns on exposure to the sun). Potential participants with bleeding diathesis, or those who were taking anti-coagulant therapy or medications known or suspected to reduce inflammation, immunity, or healing (eg corticosteroids), or those who had any chronic disease requiring ongoing medical attention, were excluded. The study was conducted according to the Declaration of Helsinki Principles and was approved by the Human Research Ethics Committee of the Queensland Institute of Medical Research and all participants gave their informed consent.
SSUV radiation
SSUV was provided by a planar bank of six 120 cm fluorescent UVA tubes (Hitachi 40W F40T 10/BL, black light, Tokyo, Japan) flanking one UVB tube (Philips TL 40W/12RS, Eindhoven, The Netherlands), with radiation filtered through a sheet of 0.125 mm cellulose acetate (Eastman Chemical Products, Kingsport, TN). This radiation source emits 2.82 Â 10 À2 W/cm 2 UVA (320-400 nm) and 9.14 Â 10 À4 W/ cm 2 UVB (290-320 nm), when measured with an Optronics OL754 integrating spectroradiometer (Orlando, FL). The spectral characteristics of this light source have been described previously (Reeve et al., 1985) . The cellulose acetate filter efficiently removes wavelengths o290 nm and results in a good approximation of the solar UV waveband.
Groups of up to five mice, unrestrained with their cage tops removed, received whole dorsal irradiation of a single moderately erythemogenic dose of 2.5 Â minimum erythemal dose (MED; established for the MT þ / þ mouse), providing 3.32 kJ/m 2 UVB, or a series of incremental daily exposures of SSUV providing 1.99, 2.65, and 3.32 kJ/m 2 UVB on days 1-3 to produce significant immunosuppression without burning. Human subjects were positioned centrally directly beneath the light source and remained prone and still for the duration of exposure. All skin surfaces were covered, except for the test sites. They received a single exposure to the lower back of 2.5 MED, calculated from their MED previously established from a graded series of incremental exposures from the SSUV source at a separate skin site.
Topical lotion
Equol was purchased from Sigma Chemical Co. (Sigma-Aldrich Australia, Castle Hill, Australia). NV-07a was synthesized as a racemic mixture of 4 0 ,7-dihydroxyisoflavane by Novogen Ltd (North Ryde, Australia). The compounds were each dissolved in DMSO, then diluted to the required concentration in an innocuous oil-in-water cosmetic lotion as described previously (Widyarini et al., 2001 (Widyarini et al., , 2005 , without color, perfume, or preservative, so that the final lotion contained various concentrations of isoflavonoids and 0.5% (vol/vol) DMSO. The isoflavonoid concentration used was considerably higher for humans than for mice, based on previous studies of NV-07a effectiveness on human skin (Friedmann et al., 2004) . The control lotion (''base lotion'') contained only 0.5% DMSO in the emulsion. The lotions were stored refrigerated in the dark.
Treatment protocol
Mice. For assay of the activation of the MT-I gene, groups of three MT þ / þ mice were exposed to a single dose of 2.5 MED of SSUV, or remained unirradiated. An aliquot of 0.1 ml of 10 mM equol or base lotion was applied to the dorsum immediately and again at 0.5 and 1 hours post-irradiation. The mice were killed and mid-dorsal skin was excised for total RNA extraction at 3 hours. For immunohistochemical detection of MT-I and -II protein expression, these treatments were repeated with 10 mM equol or base lotion applications immediately and at 4 and 6 hours post-SSUV. Skin samples were taken at 72 hours post-SSUV, as MT expression in mouse skin has been reported to continue to increase until 72 hours .
For assay of CHS, groups of five MT þ / þ and five MTÀ/À mice were irradiated on days 1-3 with incremental doses of 1.5, 2.0, and 2.5 MED of SSUV. Immediately following each irradiation, 0.1 ml lotion containing 0, 2.5, 5.0, or 10.0 mM equol was applied to the dorsal skin. When cis-urocanic acid replaced the SSUV treatment for the induction of immunosuppression, 0.1 ml of a lotion containing 0.2% photoisomerized urocanic acid (Reeve et al., 1993) , here referred to as ''cis-urocanic acid lotion'', was applied to the dorsum daily on days 1-3, and was followed at 30 minutes with 0.1 ml base lotion or 10.0 mM equol lotion each day. The lotions were lightly spread over the entire dorsal area with a gloved finger, and the mice held on the wire cage tops to discourage grooming for 15 minutes, until the lotions were absorbed.
Human volunteers. For the identification of cutaneous MT protein expression, three skin sites, each of area 5 cm 2 , were delineated on the lower back, an area not normally exposed to sunlight, of which two were exposed to 2.5 MED of SSUV and one remained protected by an aluminum mask. Following exposure, the irradiated areas were treated topically with 0.1 ml of base lotion, or 0.1 ml of 200 mM NV-07a lotion. The NV-07a or base lotion was applied immediately, at 4 hours and again at 6 hours post-SSUV, spread lightly over the area and allowed to be absorbed by the skin. We elected not to include treatment with topical NV-07a lotion and without SSUV irradiation, owing to ethical constraints on the number of biopsies to be taken from each subject. Skin biopsies were obtained aseptically using disposable, single-use, sterile 3 mm dermal biopsy punches from the untreated skin site, and at 24 hours following SSUV exposure. UVB has been reported to induce MT in human epidermis at levels fluctuating between 8 and 48 hours (Anstey et al., 1996) .
Measurement of the CHS reaction in mice
The CHS reaction to oxazolone was induced in groups of five mice by sensitization on the unirradiated abdominal skin on days 8 and 9, and the mice were challenged on the pinnae on day 15, as described previously (Reeve, 2002) . Ear thickness was measured before and repeatedly between 16 and 24 hours after the challenge, using a spring micrometer (Interapid, Geneva, Switzerland), and the average ear swelling for each group was calculated at the time of peak ear thickness in the control group (receiving base lotion only). Significance of the differences between treatments was assessed by the paired t-test.
Identification of MT mRNA in mouse skin by reverse transcriptase-polymerase chain reaction
Murine MT-1 cDNA sequence (accession no. NM_013602) and murine heme oxygenase-2 cDNA sequence (accession no. AF029874) can be located on the GenBank website (http:// www.ncbi.nlm.nih.gov/). MT-1 primers were designed (forward 5 0 -ACCCCAACTGCTCCTGCT-3 0 and reverse 5 0 -GCGCCTTTGCAGA CACAG-3 0 ) to provide a 154 bp PCR product. Primers for heme oxygenase-2, used as a control housekeeping gene, were designed (forward 5 0 -GAAGGAAGGGACCAAGGAAG-3 0 and reverse 5 0 -GTTTTAGGCAGAGGTGGAGATG-3 0 ) to generate 767 bp PCR products. The primers were synthesized by Invitrogen Life Technologies (Melbourne, Australia).
Mid-dorsal skin samples 1 Â 2 cm were taken from groups of three treated MT þ / þ mice, killed before and at 3 hours post-SSUV, and total RNA was extracted, facilitated by cutting the skin sample into 10 mm slices with a cryostat at À201C, and using the SV total RNA isolation system (Promega, Madison, WI). The RNA was reverse transcribed using the reverse transcription system (Promega A3500) and amplified using a Hybaid OmniGene thermal cycler (State Agricultural Biotechnology Centre, Murdoch, Australia). The PCR products were resolved together with a DNA molecular weight marker (GeneRuler 1 kb DNA ladder, Gronigen, The Netherlands) electrophoretically on a 1.2% agarose gel containing ethidium bromide, as described previously (Allanson and Reeve, 2004) . Gels were photographed under UV light (Kodak DC120 Digital camera, Kodak Australia Pty. Ltd, Coburg, Australia) and the images were analyzed using the ''Quantity One'' (BioRad version 4.1.1) program. MT-I was semi-quantitated after normalization with respect to the constitutively expressed heme oxygenase-2, and averaged for three mice, following SSUV treatments with base lotion or 10 mM equol lotion application as described above.
Immunohistochemical identification of MT (mouse and human skin)
Groups of three MT þ / þ mice were killed before and at 72 hours after SSUV exposure, and a transverse mid-dorsal sample was taken. Human skin was obtained before and at 24 hours following SSUV irradiation. Both mouse and human skin samples were fixed for 6 hours in Histochoice (Amresco, Parkway, OH), processed overnight with a formalin-based automated methodology, and paraffinembedded.
In the mouse, MT protein was revealed in 4 mm skin sections, using a polyclonal rabbit anti-rat MT-I and -II antibody with color development using the 3,3 0 -diaminobenzidine chromogen (Dako, Carpinteria, CA) as described previously . A monoclonal mouse anti-human MT antibody that reacts against a conserved N-terminal epitope shared by MT-I and -II (clone E9; Dako, Carpinteria, CA) was used in the human biopsies, with citric acid and microwave treatment for antigen retrieval, and color development with 3-amino-9-ethylcarbazole (Sigma) (Ablett et al., 2003) . The sections were examined by light microscopy and the images captured digitally by camera. The greater cellularity of human epidermis allowed for the enumeration of the percentage of positive -staining cells in three representative non-overlapping fields.
